Index of artpub/2017/196266/

Hájek, R
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)
2017
https://ddd.uab.cat/record/196266
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Hajek,_R2022-06-29 13:31 10  
[ ]2=A_randomized_phase_III_study_of_carfilzomib...2022-06-29 13:31 155  
[ ]3=20172022-06-29 13:31 5  
[ ]4=1962662022-06-29 13:31 34  
[TXT]196266.dirinfo2025-02-07 02:59 317  
[ ]196266.du2025-02-07 02:59 46  
[TXT]196266.dupdirs2025-02-07 02:59 0  
[TXT]196266.dupfiles2025-02-07 02:59 0  
[TXT]196266.errors2025-02-07 02:59 0  
[TXT]196266.md52025-02-07 02:59 64  
[TXT]196266.sha12025-02-07 02:59 72  
[TXT]196266.sha2562025-02-07 02:59 96  
[TXT]196266.stats2025-02-07 02:59 292  
[IMG]leukemia_a2017v31p107iENG.gif2018-10-04 17:11 43K 
[IMG]leukemia_a2017v31p107iENG.ico2018-10-04 17:11 12K 
[TXT]leukemia_a2017v31p107iENG.info2018-10-04 17:11 25K 
[ ]leukemia_a2017v31p107iENG.pdf2018-10-04 17:11 789K 
[TXT]leukemia_a2017v31p107iENG.txt2018-10-04 17:11 69K